Perspectives on
brain health innovation
Original analyses, curated readings and member portraits — the editorial voice of the BrainTech Alliance.
Selected by the Alliance.
Original analyses from Alliance members — deep-dives into the segments shaping BrainTech — alongside a curated selection of articles, reports and podcasts on brain health.
BrainTech Alliance in Paris - Session 2 Insights: From Biomarker to Product
How can biomarkers move from discovery to clinical use? Key insights from BrainTech Alliance’s second Paris roundtable on data sharing, AI-driven imaging, reproducibility and the path from scientific validation to scalable clinical products.
BrainTech Alliance
BrainTech Alliance in Paris - Session 1 Insights: Data Collection in Neuroscience
How can better data unlock AI in neuroscience? Key insights from BrainTech Alliance’s first Paris roundtable on longitudinal data, multimodal biomarkers and interoperable infrastructure.
BrainTech Alliance
BrainTech Alliance in Paris - Session 3 Insights: From Innovation to Market
BrainTech Alliance
The cerebral organoid enters its industrial era
Brain organoids are going industrial. Automation and regulatory change are unlocking scale, making biological data the new asset in AI-driven drug discovery.
BrainTech Alliance
Brain Health accelerator: transforming our understanding of brain disorders
A $400M global initiative (Allen Institute, Bezos family, AWS, NIH) targeting Alzheimer's, Parkinson's, Huntington's, ALS and Lewy body dementia.
Allen Institute
Welcome to the next phase of the Alzheimer's fight
Bill Gates on the momentum in Alzheimer's research — diagnostics, treatments and what comes next.
Gates Notes
Why neurotech is at an "AI in 2016" moment
Varun Turlapati (Chaanakya Capital) on why neurotech is at the same inflection point AI reached in 2016. 22 min.
Top Decile Podcast
Belgium: the small country quietly redefining European innovation
Growing VC activity, a strong HealthTech ecosystem and a healthcare system built for digital innovation.
Newfund
Global BrainTech funding: key trends and insights, 2023–2025
$6.3bn mapped by geography, stage, pathology and technology — the reference report on BrainTech capital allocation.
Newfund HEKA
Faces of the Alliance.
Every month, one member of the Alliance — researcher, clinician, founder or investor — sharing what the Alliance has changed for them and what they are hoping to find here.
When members join forces.
Fresh news from the Alliance — investments, clinical pilots and partnerships that started with a member introduction.
- Co-authored articleRead
Two perspectives on the future of brain organoids
Constant Beroulle (Newfund) x Petra Szeszula (Brainzell)
- PartnershipRead
A dealflow-sharing partnership
ARIA (research funder) × Nexus Neurotech / Ground Effect Ventures (investor)
- InvestmentRead
Two members, one bet: co-investing in Ampa
Ampa Health (startup) × Satori Capital × Nexus Neurotech (investors)
- InvestmentRead
A seed round for NeuraWorx
NeuraWorx (startup) × Nexus Neurotech (lead) with Verge Fund, RPV and Foothill Ventures (co-investors)
Where the brain community meets, beyond our own gatherings.
Neurotech Leaders Forum 2026
November 9–10, 2026 — South San Francisco, CA
The two-day investment and management conference for neurotechnology entrepreneurs and executives, by Neurotech Reports.
Visit event siteBrain Innovation Days
Annual — Brussels, Belgium
The European gathering fostering dialogue, knowledge exchange and investment across the brain research and innovation ecosystem.
Visit event siteSubscribe to the BrainTech briefing.
One email a month — original analyses, member portraits and the most relevant reads from the ecosystem.